The psychological impact of the follow up procedures

ESGO eAcademy, Eva Greimel, 62418

Risk of secondary cancer after treatment of gynaecological cancer

ESGO eAcademy, David Cibula, 62417

The role of the imaging (CT-RMI-PET/CT) in the follow up

ESGO eAcademy, Nandita de SOUZA, 62416

The role of ultrasound procedures in the follow up

ESGO eAcademy, Manuela LUDOVISI, 62415

Follow up in Gynaecological Malignancies : a challenge

ESGO eAcademy, Paolo Zola, 62414

Beyond the medical aspect: the point of view of the patient

ESGO eAcademy, Paola MOSCONI, 62413

Sexuality and Cancer

ESGO eAcademy, Woet Gianotten & Annette Hasenburg, 58162

Managing Suicide Risk in Cancer Patients

ESGO eAcademy, Maggie Watson & Luigi Grassi, 58153

Classical laparoscopical surgery for hysterectomy, indication and outcome

ESGO eAcademy, Andreas Müller, 63140

Drugable Targets in Ovarian Cancer

ESGO eAcademy, MICHAEL BIRRER, 55524

Early Trials for Targeted Therapy: Specificity and Pitfalls

ESGO eAcademy, Cristiana Sessa, 55523

Panel Discussion

ESGO eAcademy, Session Speakers, 56036

Endpoints in Clinical Trials

ESGO eAcademy, Nicoletta Colombo, 55522

Improvement in Treatment for Ovarian Cancer: a 40 Year Journey

ESGO eAcademy, Stan Kaye, 55520

Critical Review of Clinical Trials - What We Learn from Negative Trials and Where Are We Going?

ESGO eAcademy, Christian Marth, 55519

Panel Discussion

ESGO eAcademy, Session Speakers, 56035

Elderly: the US Perspective

ESGO eAcademy, Bradley J. Monk, 55518

Endpoints and Trial Design in Geriatric Oncology

ESGO eAcademy, Sandro Pignata, 55517

Specificity of Elderly and Chemotherapy

ESGO eAcademy, Gilles Freyer, 55516

How To Calculate Costs of Clinical Trials

ESGO eAcademy, Jacobus Pfisterer, 55515

How To Incorporate Translational Research in Trials - Lessons from Anti-Angiogenic Trials

ESGO eAcademy, MICHAEL BIRRER, 55514

Regulatory Awareness Programme - Regulated Markets

ESGO eAcademy, Andrea Laslop, 65036

Clinical Trial Phases

ESGO eAcademy, Regina Berger, 57604

What is a clinical trial?

ESGO eAcademy, Regina Berger, 57603

Inguinal Lymphadenectomy: Reducing Dehiscence Rate

ESGO eAcademy, Ignacio Zapardiel, 95018

Single Port Extraperitoneal Paraaortic Lymphadenectomy

ESGO eAcademy, Ignacio Zapardiel, 95019

Video Endoscopic Inguinofemoral Lymphadenectomy in Vulvar Cancer

ESGO eAcademy, Alvaro Zapico, 95020

Ultrasound Based Interventions in Gynecologic Oncology

ESGO eAcademy, Michal Zikan, 95021

Modified Gluteal Fold Advancement V-Y Flap for Vulva Reconstruction

ESGO eAcademy, Pierluigi Benedetti Panici, 94962

Pitfalls and Secondary Profit of Daphragmatic Surgery in Advanced Stages of Endometrial and Ovarian Cancer

ESGO eAcademy, Lucie Bresson, 94963

Salvage Surgery for Retroperitoneal Lymph Node Reccurence

ESGO eAcademy, David Cibula, 94964

Splenectomy with Total Omentectomy

ESGO eAcademy, David Cibula, 94965

Standardization of Type C2 Radical Hysterectomy

ESGO eAcademy, David Cibula, 94966

Perineal Pelvic Repair after Posterior Exenteration in an Epistotomy: Metastasis of Cervical Carcinoma

ESGO eAcademy, Santiago Domingo, 94967

RH in LACC Neoadjuvant RT-CHT

ESGO eAcademy, Francesco Fanfani, 94968

Ultrasound Imaging for Staging Supplemented by Corresponding Intraoperative Findings

ESGO eAcademy, Daniela Fischerova, 94969

Surgical Steps in Type B and C Laparoscopic Radical Hysterectomy: Tips and Tricks

ESGO eAcademy, Juan Gilabert-Estelles, 94970

Surgical Vascular Anatomy on the Upper Abdomen

ESGO eAcademy, Luis M. Chiva, 94971

Radical Abdominal Trachelectomy

ESGO eAcademy, Nicolae Ioanid, 94972

Sigmoid Colon Vaginoplasty

ESGO eAcademy, Ates Karakete & Ilker Kahramanoglu, 94973

Paraaortic Recurrence - Laparoscopic Resection: Retroperitoneal Approach

ESGO eAcademy, Tim Mould, 94975

Radical Resection of Intravascular and Intracardiac Tumor

ESGO eAcademy, Pedro T Ramirez, 94976

Robotic Flourescent Sentinel Node Identification in Endometrial Cancer

ESGO eAcademy, Diego Odetto, 94977

Robotic Radical Trachelectomy

ESGO eAcademy, Pedro T Ramirez, 94978

Cytoreductive Surgery & Pathophysiology of Peritoneal Carcinomatosis

ESGO eAcademy, Francesco Raspagliesi, 94979

Upper Abdominal Debulking Procedures

ESGO eAcademy, Cagatay Taskiran, 94980

Laparoscopic Access & Operating in the Retroperitoneal Space - Challenges & Pitfalls

ESGO eAcademy, Martin Widschwendter, 94981

Advanced Ovarian Cancer: Video Presenting Ultrasound Imaging for Staging Supplemented by Corresponding Intraoperative Findings

ESGO eAcademy, Daniela Fischerova, 95029

Ovarian Cancer: Cytoreductive Surgery & Pathophysiology of Peritoneal Carcinomatosis

ESGO eAcademy, Francesco Raspagliesi, 95039

CANCER DURING PREGNANCY: THE OBSTETRICAL POINT OF VIEW

ESGO eAcademy, Kristel Van Calsteren, 39121

IDENTIFICATION OF OVARIAN CANCER PATIENTS AT HIGH RISK OF SURGICAL MORBIDITY AND MORTALITY

ESGO eAcademy, Giovanni Aletti, 39122

MANAGEMENT OF GYNECOLOGIC SOFT TISSUE SARCOMA AFTER COMPLETE RESECTION

ESGO eAcademy, Isabelle Ray-Coquard, 39123

VULVAR CANCER WITH POSITIVE NODES OF THE GROIN - PELVIC LYMPHADENECTOMY, ADJUVANT RADIOTHERAPY OR RADIOCHEMOTHERAPY?

ESGO eAcademy, Sven Mahner, 39124

ISOLATED TUMOUR CELLS AND MICROMETASTASES: HOW TO DEAL WITH IT?

ESGO eAcademy, Nadeem Abu Rustum, 39125

PITFALLS IN SENTINEL NODE DETECTION IN VULVAR CANCER: AN IN DEPTH ANALYSIS OF FALSE NEGATIVE CASES

ESGO eAcademy, Maaike Oonk, 39126

QUALITY OF LIFE AND SURVIVAL AFTER SN BIOPSY. RESULTS OF THE SENTICOL II, RANDOMIZED TRIAL

ESGO eAcademy, Patrice Mathevet, 39127

ENDOMETRIAL CANCER: PREOPERATIVE ULTRASOUND ASSESSMENT TO TAILOR SURGERY

ESGO eAcademy, Elisabeth Epstein, 39118

NEW IMAGING TECHNOLOGY IN OVARIAN CANCER

ESGO eAcademy, Ate G.J. van der Zee, 39119

ULTRASOUND VERSUS MRI IN CERVICAL CANCER STAGING AND INDIVIDUAL TREATMENT PLANNING

ESGO eAcademy, Daniela Fischerova, 39120

IMAGING PRE-INVASIVE TUBAL LESIONS IN HIGH RISK POPULATIONS

ESGO eAcademy, Jessica McAlpine, 39112

TUBAL PATHOLOGY IN BRCA 1 AND 2 MUTATION CARRIERS

ESGO eAcademy, Ronny Drapkin, 39114

CONTROVERSIES IN ADJUVANT THERAPY

ESGO eAcademy, Wui-Jin Koh, 39115

CONTROVERSIES IN THE MANAGEMENT OF ADVANCED CASES IN VULVAR CANCER

ESGO eAcademy, Lukas Rob, 39116

CURRENT STATUS OF SENTINEL LYMPH NODE MAPPING IN VULVAR CANCER

ESGO eAcademy, Ate G.J. van der Zee, 39117

IMPLICATIONS FOR FUTURE RESEARCH

ESGO eAcademy, Ignace Vergote, 39341

REVIEW OF IMPLICATIONS FOR CLINICAL PRACTICE - US VIEW

ESGO eAcademy, Sean C. Dowdy, 39339

REVIEW OF IMPLICATIONS FOR CLINICAL PRACTICE - EUROPEAN VIEW

ESGO eAcademy, Nicoletta Colombo, 39338

COMPLICATIONS AND MORTALITY ASSOCIATED WITH PRIMARY OPTIMAL CYTOREDUCTION

ESGO eAcademy, Angelo Maggioni, 39109

NEOADJUVANT CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER

ESGO eAcademy, Ignace Vergote, 39110

PREOPERATIVE AND LAPAROSCOPIC EVALUATION FOR OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER

ESGO eAcademy, Giovanni Scambia, 39111

GUIDELINES AND LEVEL OF EVIDENCE FROM THE TRIALS

ESGO eAcademy, John A Green, 39105

Treatment-Surgery-Lymph Nodes- Radiotherapy- Chemotherapy- Individualization- Recurrence

ESGO eAcademy, Paolo Zola, 39106

WHAT IS ENDOMETRIAL CANCER - PATHOLOGY, MOLECULAR CHARACTERISATION ETC, EPIDEMIOLOGY

ESGO eAcademy, Glenn McCluggage, 39108

IS THE THERAPY-FREE INTERVAL OF 6 MONTHS STILL A USEFUL MODEL FOR GUIDING 2NDLINE OR HIGHER THERAPIES IN OVARIAN CANCER?

ESGO eAcademy, Daniel U. Reimer, 39100

TREATMENT CONSIDERATIONS IN CERVICAL CANCER WITH PELVIC RECURRENCE AFTER ADJUVANT OR PRIMARY RADIOCHEMOTHERAPY

ESGO eAcademy, Stefano Greggi, 39101

TREATMENT CONSIDERATIONS IN PATIENTS WITH RECURRENT CARCINOMATOSIS AFTER SEVERAL LINES OF CHEMOTHERAPY AND SUBILEUS/ILEUS

ESGO eAcademy, Philip Harter, 39102

TREATMENT CONSIDERATIONS IN VULVA CARCINOMA WITH LOCO-REGIONAL RECURRENCE

ESGO eAcademy, Ate G.J. van der Zee, 39103

PROGRESS IN RISK PREDICTION, DIAGNOSIS AND SCREENING FOR OVARIAN CANCER

ESGO eAcademy, Ian Jacobs, 39099

Vaginal Trachelectomy + Laparoscopic LND

ESGO eAcademy, Achim Schneider, 39134

Surgical Staging of Cervical Carcinoma and Extraperitoneal LND

ESGO eAcademy, Eric Leblanc, 39135

ROBOTIC SURGERY FOR THE MANAGEMENT OF CERVICAL CANCER

ESGO eAcademy, Angelo Maggioni, 39136

Vulva Cancer: VFR and Recostruction with Flaps

ESGO eAcademy, Nadja Dornhöfer, 39138

SLN in Vulvar Cancer

ESGO eAcademy, Ate G.J. van der Zee, 39139

PALLIATIVE AND END OF LIFE CARE IN GYNECOLOGICAL CANCER - GOING BEYOND THE PHYSICAL

ESGO eAcademy, Mari Lloyd-Williams, 39097

PALLIATIVE CARE - END OF LIFE CARE IN GYNECOLOGICAL CANCER : ASPECTS OF CLINICAL PRACTICE

ESGO eAcademy, Johan Menten, 39098

Cancer: A Family Affair

ESGO eAcademy, Lea Baider, 48149

Anxiety and Adjustment Disorders in Cancer Patients

ESGO eAcademy, Katalin Muszbek, 48150

Loss, Grief and Bereavement

ESGO eAcademy, David Kissane, 48151

Palliative Care for the Psycho-Oncologist

ESGO eAcademy, William Breitbart, 48152

Ethical Implications of Psycho-Oncology

ESGO eAcademy, Antonella Surbone, 48153

Psychosocial Interventions: Evidence and Methods for Supporting Cancer Patients

ESGO eAcademy, Maggie Watson & Barry Bultz, 48154

Psychosocial Assessment in Cancer Patients

ESGO eAcademy, Uwe Koch & Anja Mehnert, 48155

Communication and Interpersonal Skills in Cancer Care

ESGO eAcademy, Walter F. Baile, 48156

Distress Management in Cancer

ESGO eAcademy, Jimmie C. Holland, 48157

Depression and Depressive Disorders in Cancer Patients

ESGO eAcademy, Luigi Grassi & Yosuke Uchitomi, 48158

Guideliness and Evidence from the Trials about Follow up

ESGO eAcademy, Elisa Piovano, 45901

PERSONALIZED SURGICAL CARE FOR CERVICAL CANCER

ESGO eAcademy, Rene H.M. Verheijen, 39091

SENTINEL NODE CONCEPT AND RELEVANCE OF DETECTION OF MICROMETASTASES

ESGO eAcademy, David Cibula, 39092

(NEO-) ADJUVANT CHEMOTHERAPY AND CERVICAL CANCER

ESGO eAcademy, Roberto Angioli, 39093

NO HEALTH WITHOUT MENTAL HEALTH: THE IMPORTANCE OF PSYCHOSOCIAL CARE IN GYNAECOLOGICAL CANCER

ESGO eAcademy, Maggie Watson, 39083